JOURNAL OF COSMETIC SCIENCE 312 (10) OECD, Test N o . 107: Partition Coeffi cient (n-octanol/water): Shake Flask Method, OECD Publishing, Paris, France (1995). (11) ACD/Labs, Par tition Coeffi cient Calculation with ACD/LogP, Advanced Chemistry Development, Inc., 2019, accessed June 21, 2019, https://www.acdlabs.com/products/percepta/predictors/logp/. (12) I. V. Tetko, J. Gasteiger, R. Todeschini, A. Mauri, D. Livingstone, P. Ertl, V. A. Palyulin, E. V. Radchenko, N. S. Zefi rov, A. S. Makarenko, V. Y. Tanchuk, and V. V. Prokopenko, Virtual computa- tional chemistry laboratory - design and description. J. Comput. Aided Mol. Des., 19, 453–463 (2005). (13) S. Gaisford, “Pharmaceutical preformulation,” in Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, 5th Ed., M. E. Aulton and K. M. G. Taylor. Eds. (Churchill Livingstone, London, 2018), pp. 391–392. (14) ACDLabs, ACD / ChemSketch.12.01 edn (Advanced Chemistry Development, Inc., Toronto, 2009). (15) S. Gaisford, “Pharmaceutical preformulation,” in Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, M. Aulton and K. Taylor. Eds. (Churchill Livingstone, London, 2018), pp. 402. (16) J. Dandurand , V. Samouillan, M. H. Lacoste-Ferre, C. Lacabanne, B. Bochicchio, and A. Pepe, Confor- mational and thermal characterization of a synthetic peptidic fragment inspired from human tropoelas- tin: signature of the amyloid fi bers, Pathol. Biol., 62, 100–107 (2014). (17) J. E. Noble a nd M. J. Bailey, Quantitation of protein, Methods Enzymol., 463, 73–95 (2009). (18) A. R. Field, J. Fink, R. Dux, G. Fußmann, U. Wenzel, and U. Schumacher, A spatially scanning vacuum ultraviolet and visible range spectrometer for spectroscopy of tokamak plasmas in ASDEX-Upgrade, Rev. Sci. Instrum., 66, 5433–5441 (1996). (19) B. B. Stephens, R. F. Keeling, and W. J. Paplawsky, Shipboard measurements of atmospheric oxygen using a vacuum-ultraviolet absorption technique, Tellus B Chem. Phys. Meteorol., 55, 857–878 (2011). (20) N. J. Anthis and G. M. Clore, Sequence-specifi c determination of protein and peptide concentrations by absorbance at 205 nm, Protein Sci., 22, 851–858 (2013). (21) X. Zhu, R. Zou, P . Sun, Q. Wang, and J. Wu, A supramolecular peptide polymer from hydrogen-bond and coordination-driven self-assembly, Polym. Chem., 9, 69–76 (2017). (22) F. F. de Sousa, C . E. S. Nogueira, P. T. C. Freire, S. G. C. Moreira, A. M. R. Teixeira, A. S. de Menezes, J. Mendes Filho, and G. D. Saraiva, Conformational change in the C form of palmitic acid investigated by Raman spectroscopy and X-ray diffraction, Spectrochim. Acta, 161, 162–169 (2016). (23) E. Moreno-Calvo, R. Cordobilla, T. Calvet, F. Lahoz, and A. I. Balana, The C form of n-hexadecanoic acid, Acta Crystallogr. C, 62, o129–o31 (2006). (24) S. Namjoshi, I. T oth, J. Blanchfi eld, N. Trotter, R. Mancera, and H. E. Benson, Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mecha- nistic insights, Pharm. Res., 31, 3304–3312 (2014). (25) K. Setoh, M. Mur a kami, N. Araki, T. Fujita, A. Yamamoto, and S. Muranishi, Improvement of trans- dermal delivery of tetragastrin by lipophilic modifi cation with fatty acids, J. Pharm. Pharmacol., 47, 808–811 (1995). (26) J. Møss and H. B u ndgaard, Prodrugs of peptides. 7. Transdermal delivery of thyrotropin-releasing hor- mone (TRH) via prodrugs, Int. J. Pharm., 66, 39–45 (1990). (27) Y. L. Choi, E. J. Park, E. Kim, D. H. Na, and Y. H. Shin, Dermal stability and in vitro skin permeation of collagen pentapeptides (KTTKS and palmitoyl-KTTKS), Biomol Ther., 22, 321–327 (2014). (28) I. W. Hamley, Sel f -assembly of amphiphilic peptides, Soft Matter, 7, 4122–4138 (2011). (29) A. Patist, S. S. B hagwat, K. W. Penfi eld, P. Aikens, and D. O. Shah, On the measurement of critical micelle concentrations of pure and technical-grade nonionic surfactants, J. Surfactants Deterg., 3, 53–58 (2000). (30) A. R. Bilia, L. S c alise, M. C. Bergonzi, and F. Vincieri, Effect of surfactants and solutes (glucose and NaCl) on solubility of Kavain--a technical note, AAPS PharmSciTech, 9, 444–448 (2008). (31) ProImmune, Workin g with Peptides. ProImmune Limited, 2012, accessed December 18, 2018. https:// www.proimmune.com/ecommerce/pdf_fi les/ST55.pdf.
J. Cosmet. Sci., 70, 313–325 (November/December 2019) 313 Utilization of Coffee Silverskin By-Product from Coffee Roasting Industry through Extraction Process for the Development of Antioxidant Skin Gel SAMUEL P. KUSUMOCAHYO, PATRICK TANGGUH, CHRISTINA D. ANNELIES, and HERY SUTANTO , Department of Chemical Engineering, Faculty of Life Sciences & Technology, Swiss German University, Tangerang 15143, Indonesia (S.P.K., P.T., C.D.A., H.S.) Accepted for publication October 4, 2019. Synopsis Coffee roasting industries generate a by-product called coffee silverskin that is usually disposed of as waste. The valorization of this abundant waste is necessary because of the antioxidant compounds in coffee silverskin. In this study, coffee silverskin was extracted in different extraction conditions to obtain an extract with high antioxidant activity and to use it as an additive for antioxidant skin gel. The extracts were characterized for the total phenolic content by using the Folin–Ciocalteu method. The antioxidant activity was determined by using the 2,2-diphenyl-1-picrylhydrazyl free radical scavenging assay. It was found that the extraction time and temperature strongly affected the total phenolic content and the antioxidant activity of the extracts. The extraction at 40°C and 60 min resulted in an extract with a high total phenolic content of 31.15 ± 2.77 mg Gallic Acid Equivalent/g coffee silverskin and a high antioxidant activity of 68.44 ± 0.76%. The extract solution was spray-dried to produce extract powder, which was then added to a basic skin gel with different extract concentrations. It was observed that the antioxidant activity of the gel increased with increasing extract concentration in the gel. This result showed that coffee silverskin has great potential as a source of antioxidants for various skin care products. IN TRODUCTION Anti oxidants are very important for the human body because they protect the human body against reactive oxygen species, known as free radicals, which can cause oxidative reac- tions in human cells. Although the human body has an internal defense system toward free radicals (1), it still requires the intake of antioxidants from outside that usually can be obtained from synthetic or natural products, such as fruits and vegetables, containing antioxidants (2). Recently, the interest in natural products for healthy foods, beverages, supplements, and health care products has been rising along with the increasing aware- ness of a healthy life style (3–5). Address all correspondence to Samuel P. Kusumocahyo at samuel.kusumocahyo@sgu.ac.id.
Previous Page Next Page